Cantor Fitzgerald’s DA32 Life Science Tech Acquisition Corp DALS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-368,606
Closed -$3.78M – 681
2023
Q2
$3.78M Hold
368,606
– – 0.09% 216
2023
Q1
$3.73M Hold
368,606
– – 0.08% 260
2022
Q4
$3.68M Buy
368,606
+90,019
+32% +$886K 0.08% 270
2022
Q3
$2.71M Buy
278,587
+113,753
+69% +$1.11M 0.06% 303
2022
Q2
$1.6M Buy
+164,834
New +$1.6M 0.03% 396

Cantor Fitzgerald's DALS Position: Q3 2023 in Review

Cantor Fitzgerald sold out of DA32 Life Science Tech Acquisition Corp (DALS) in Q3 2023, closing a stake of 368,606 shares — an estimated $3.78M sold.

Cantor Fitzgerald first reported a position in DALS in Q2 2022 and held it in 5 quarters. The position peaked at $3.78M in Q2 2023. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.

  • Cantor Fitzgerald reported no remaining DA32 Life Science Tech Acquisition Corp position as of Q3 2023 after selling out during the quarter.
  • Cantor Fitzgerald sold 368,606 DA32 Life Science Tech Acquisition Corp shares in Q3 2023, an estimated $3.78M.
  • Cantor Fitzgerald first reported a position in DA32 Life Science Tech Acquisition Corp in Q2 2022 and held it in 5 quarters.
  • Cantor Fitzgerald's DA32 Life Science Tech Acquisition Corp position peaked at $3.78M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp as of Q3 2023.

Based on Cantor Fitzgerald's 13F filing for Q3 2023, filed 14 Nov 2023.